Cited by 911Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Statins: mechanism of action and effects

Open access

Stancu, Camelia, Sima, Anca·2001·Journal of Cellular and Molecular Medicine

DOI 10.1111/j.1582-4934.2001.tb00172.xPMC PMC6740083

Open this paper in CoChat — free account Open PDF

Abstract

The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2001.tb00172.x

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Coronary Plaque Disruption
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors: Similarities and Differences
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512

Show all 42 references

Research works printed but not linked: 2

Voet D., 1995, Biochemistry, 315
StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).

Sorted by citations

Items 601–700 of 910

Role of Statins in the Clinical and Radiologic Outcomes of Patients with Unruptured Intracranial Aneurysm Undergoing Microsurgery or Endovascular Treatment: A Systematic Review and Meta-Analysis
Habibi, M. A., Alavi, S. A. N., Mirjani, M. S., Aliasgary, A., Delbari, P., Ahmadvand, M. H., Hatami, S., Hasan, Z., Dmytriw, A. A., & Kobets, A. J. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.11.080 · Cited by 3
Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes
Hwang, S., Karhunen, V., Patel, A., Lockhart, S. M., Carter, P., Whittaker, J. C., & Burgess, S. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf223 · Cited by 3
Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor
Gurzeler, E., Aavik, E., Laine, A., Valkama, T., Niskanen, H., Huusko, J., Kaikkonen, M. U., & Ylä‐Herttuala, S. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.11.012 · Cited by 3
A Review on Synthesis and Applications of Statin Family Drugs as a New Generations of Anti-Blood Medicines
Safapoor, S., Yazdani, H., & Shahabi, P. (2020) · Journal of Chemical Reviews · doi:10.33945/sami/jcr.2020.1.1 · Cited by 3
The case for statin use to reduce perioperative adverse cardiovascular and cerebrovascular events
Ratcliffe, F. M., & Rothwell, P. M. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.01.010 · Cited by 3
Simvastatin ointment in the treatment of seven childhood diffuse plane xanthomas
Xia, Y., Yang, L., Gu, Y. H., Zhang, W., Zhang, Z., Guo, Y., & Yao, Z. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15649 · Cited by 3
Hepatic histopathological and morphometric changes in male mice exposed to rosuvastatin from pre-puberty to adulthood: a possible adaptive hepatic response
Knorst, J. K., de Mello, T. F., Oltramari, A. R., da Silva, A. S., & Leite, G. A. A. (2024) · Drug and Chemical Toxicology · doi:10.1080/01480545.2024.2385609 · Cited by 3
Statins in the Cause and Prevention of Cancer: Confounding by Indication and Mediation by Rhabdomyolysis and Phosphate Toxicity
Brown, R. B. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11090296 · Cited by 4
Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database
Deng, B., Li, S., You, R., & Fu, Z. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2418325 · Cited by 3
The role of statins in breast cancer survivors
Bashey, S. Z., Kordon, A. C., Ositelu, K. C., Rao, A., & Akhter, N. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07605-2 · Cited by 3
Breast cancer metastatic dormancy and emergence, a role for adjuvant statin therapy
Beckwitt, C. H. (2018) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study
Kameyama, N., Maruyama, C., Shijo, Y., Umezawa, A., Sato, A., Ayaori, M., Ikewaki, K., Waki, M., & Teramoto, T. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.52316 · Cited by 3
A Lipid lover’s Guide to Novel Therapeutics for Lipid and Cardiovascular Risk Reduction
Hritani, R., Hussain, A., Saeed, A., & Agarwala, A. (2021) · Future Cardiology · doi:10.2217/fca-2020-0216 · Cited by 3
Fluvastatin Reduces Glucose Tolerance in Healthy Young Individuals Independently of Cold Induced BAT Activity
Felder, M., Maushart, C. I., Gashi, G., Senn, J. R., Becker, A. S., Müller, J., Baláž, M., Wolfrum, C., Burger, I. A., & Betz, M. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.765807 · Cited by 3
A New Perspective on the Development of Cholesterol- Lowering Products
Sandhya, V. G., & Wang, Y. (2013) · InTech eBooks · doi:10.5772/54729 · Cited by 2
Experimental atheroma formation in the coronary artery of the hyperlipemic hamster
Sima, A. V. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00195.x · Cited by 3
Self-citation
Efficacy of cholesterol uptake inhibition added to statin therapy among subjects following a low-carbohydrate diet: A randomized controlled trial
Chirinos, J. A., Williams, M. M., Bregman, D. B., Ashfaq, H., Khayyam, U., & Iqbal, N. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.02.010 · Cited by 3
THE HYPOCHOLESTEROLEMIC EFFECT OF PROBIOTICS IN THE HYPERLIPIDEMIC HAMSTER
Stancu, C. S., Serbancea, F., Botez, G. M., & Sima, A. V. (2008) · Cited by 3
Self-citation
Phytosterols and Micronutrients for Heart Health
Spitzer, V., & Maggini, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-396485-4.00024-4 · Cited by 3
Pharmacogenomics of Blood Lipid Regulation
Legault, M., Tardif, J., & Dubé, M. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0007 · Cited by 4
The particulars of certain drugs’ effect on the endogenous coenzyme Q10 plasma level in patients with cardiovascular diseases
Ших, Е. В., Zozina, V. I., Kondratenko, S. N., Melnikov, E. S., & Kukes, V. G. (2020) · Drug metabolism and drug interactions · doi:10.1515/dmpt-2020-0106 · Cited by 3
Mouse NTCP–Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice
Russell, L. E., DeGorter, M. K., Ho, R. H., Leake, B. F., Schmerk, C. L., Mansell, S. E., & Kim, R. B. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00540-2 · Cited by 3
In vitro 3-Hydroxy-3-methylglutaryl-coenzyme: A reductase inhibition assay of triphala ayurvedic formulation
Rinthong, P., & Mudjupa, C. (2020) · Pharmacognosy Research · doi:10.4103/pr.pr_68_20 · Cited by 3
Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-alpha on Diabetes Patient with Dyslipidemia
Melasari, W. P., Suharjono, S., & Samsulhadi, W. (2021) · Folia Medica Indonesiana · doi:10.20473/fmi.v57i1.26326 · Cited by 3
Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
Linz, D., Verheule, S., Isaacs, A. J., & Schotten, U. (2021) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.51 · Cited by 3
Atherosclerosis
Mayer, F., & Binder, C. J. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-12270-6_10 · Cited by 3
Significance of traditional herbal medicine for dyslipidemia.
Kang, Y., Kim, Y.-J., & Kim, K. (2023) · PubMed Central · Cited by 3
Atorvastatin ameliorates the contractile dysfunction of the aorta induced by organ culture
Zhou, F., Rao, F., Deng, Y., Yang, H., Kuang, S., Wu, F., Wu, S., Xue, Y., Wu, X., & Deng, C. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1559-4 · Cited by 3
Effect of atorvastatin to RANKL/OPG system in patients with acute coronary syndrome
Pérez-Castrillón, J.-L., Abad, L., Vega, G., Sanz-Cantalapiedra, A., San Miguel, A., Mazón, A., Sanchez, S., Hernandez, G., & Dueñas‐Laita, A. (2005) · TECNALIA Publications (Fundación TECNALIA Research & Innovation) · Cited by 3
Consideration of T-Cell Profile in the Examination of Statin Efficacy in Inflammatory Diseases, Neurodegeneration, and Neurocognitive Performance
Hintermayer, M. A., Mendelson, D., & Byun, J. H. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae156 · Cited by 2
Curbside Consult Optimizing Statin Therapy in the Elderly: A Personalized Approach to Cardiovascular Disease Prevention
Maheta, D., Agrawal, S. P., Patel, J., Patel, M., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000848 · Cited by 2
Improved fast reversed-phase HPLC using factorial design for concurrent analysis of ramipril, atorvastatin, and clopidogrel in laboratory synthesized tablet
Rashad, E. A., Elsayed, S. S., Nasr, J. J., & Ibrahim, F. A. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.112804 · Cited by 2
Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan
Tu, K.-C., Chang, W., Lin, H.-W., Lin, P., Wu, Y., Lin, C., Yeh, H., Charng, M., Huang, P., Lin, T., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02431-8 · Cited by 2
Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms
Feng, X., Huang, C., Tong, X., Wen, Z., Zhu, Y., Huang, M., Lin, J., Huang, J., Yuan, H., Xu, A., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.049833 · Cited by 2
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?
Xu, Q., Opoku, Y. N., Authi, K. S., & Cilibrizzi, A. (2025) · Cells · doi:10.3390/cells14151219 · Cited by 2
High serum LDL promotes EMT and stemness through LDLR/FOXQ1/NF-κB1 pathway in epithelial ovarian cancer
Tang, S., Chen, K., Zheng, F., Fu, Z., Niu, Y., Liu, X., Ni, H., Yuan, X., Cui, Z., Lv, W., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03609-4 · Cited by 2
Repurposing statins for choriocarcinoma: targeting the mevalonate pathway to disrupt mechanosignaling and overcome therapeutic resistance
Alshaikh, A. B. A., Al-Kuraishy, H. M., Kafy, S. M., Abdelaziz, A. M., & Batiha, G. E. (2026) · Clinical & Experimental Metastasis · doi:10.1007/s10585-026-10395-0 · Cited by 2
Uncovering Coenzyme Q10 ‐Related Genetic Determinants of Statin‐Associated Muscle Symptoms: Evidence from the UK Biobank and the All of Us Research Program
Lee, D. H., Park, Y., Song, Y., Han, J., Choi, K. H., Kim, M. G., & Gwak, H. S. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70325 · Cited by 2
Cholesterol in Mitochondrial Diseases—Friend or Foe?
Taylor, M., Halicki, M., & Chazot, P. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104353 · Cited by 2
Alzheimersche Demenz, Cholesterin und Statine: Berührungspunkte wichtiger Stoffwechselwege
Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie · doi:10.1002/ange.201204964 · Cited by 2
Propensity-matched analysis of the influence of perioperative statin therapy on outcomes after liver resection
Dasari, B. V. M., Pathanki, A. M., Hodson, J. A., Roberts, K. J., Marudanayagam, R., Mirza, D. F., Isaac, J., Sutcliffe, R. P., & Muiesan, P. (2019) · BJS Open · doi:10.1002/bjs5.50155 · Cited by 2
Severe aortic valve stenosis with rapidly progressive atherosclerosis in a young woman with homozygous familial hypercholesterolemia: the possibilities of surgical and therapeutic treatment
Чубыкина, У. В., Владиславович, Е. М., Saidova, M. A., Эмвярович, И. Т., Tmoyan, N. A., Прокопьевич, М. П., Алексеева, И. А., Kabardieva, M. R., Колегаев, А. С., Lepilin, P. M., et al. (2021) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20211602165 · Cited by 2
Kinetic study of degradation of Rosuvastatin calcium to Rosuvastatin-lactone under different solvents conditions
Ghanem, R. A., Delmani, F. A., Yousef, F. O., AL-Kayed, A., Al‐Sa'doni, H. H., Al‐Sou'od, K. A., Almashaqbeh, O. K., Rabi, M. E., & Abdo, A. (2023) · Chemical Papers · doi:10.1007/s11696-023-02864-7 · Cited by 2
Dyslipidemia in Metabolic Syndrome
Toh, S.-A. E. S., & Lee, M. H. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_58-1 · Cited by 2
Allo-polyherbal Approaches for Managing Metabolic Syndrome: A Narrative Review
Sharma, P., Singh, V., & Baldi, A. (2023) · The Natural Products Journal · doi:10.2174/0122103155272968231003030032 · Cited by 2
Effects of Different Forms of Statins on Lipid Profile in Hyperlipidemic Patients
Bahar, A. T., Caner, T., Elif, A., stemiha, T., Nicolas, R. R., Faikoğlu, G., Kübra, S. S.-F., Uskur, T., Grassi, G. M., & Francesco, F. (2023) · International Journal of Pharmacology · doi:10.3923/ijp.2023.708.713 · Cited by 2
Selected widely prescribed pharmaceuticals: toxicity of the drugs and the products of their photochemical degradation to aquatic organisms
Klementová, Š., & Poncarová, M. (2024) · Journal of Applied Biomedicine · doi:10.32725/jab.2024.007 · Cited by 2
OS TIPOS DE TRATAMENTOS ATUALMENTE DISPONÍVEIS PARA DISLIPIDEMIA E CONTROLE DOS TRIGLICERÍDEOS
Nogueira, D. R., Melo, G. C. D. C., Silva, I. D. A. C. E., Moreira, L. E. P., Pedrosa, M. D. S. B., Cardinali, M. D. P., Peron, P. L. V., & Piazzi, R. G. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024264p13 · Cited by 2
Influence of Statins and Fibrates Drugs on Bone Health and Regeneration
Santiago, O., Ruggieri, I. N. C., Paulini, M. R., Fazan, V. P. S., Issa, J. P. M., & Feldman, S. (2024) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2024.151001 · Cited by 3
Prolonged exposure to simvastatin affects coenzyme Q9/10 status leading to impaired mitochondrial respiratory capacity and reduced viability of cultured cardiac cells
Mthembu, S. X. H., Mazibuko-Mbeje, S. E., Silvestri, S., Orlando, P., Nkambule, B. B., Muller, C. J. F., Tiano, L., & Dludla, P. V. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106052 · Cited by 2
Influence of statin intervention on peripheral neuropathy in patients treated with anticancer drugs identified from the insurer database
Aizawa, F., Yagi, K., Sato, M., Niimura, T., Goda, M., Izawa‐Ishizawa, Y., & Ishizawa, K. (2025) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-025-00428-3 · Cited by 2
Enhanced Efficacy of Low-dose Lovastatin Through Probiotic-Mediated Absorption: Insights From In Vitro and In Vivo Studies
Li, B., Kwok, L., Wang, D., Li, L., Zhang, H., & Chen, Y. (2025) · Engineering · doi:10.1016/j.eng.2025.04.017 · Cited by 2
Development and Characterization of Binary Solid Lipid Nano Suspension of Atorvastatin: In-Vitro Drug Release and In-Vivo Pharmacokinetic Studies
Kamran, M., Khan, M. A., Shafique, M. S., Rehman, M. U., Ahmed, W., Abdullah, & Ahmad, S. (2019) · Nanoscience and Nanotechnology Letters · doi:10.1166/nnl.2019.3039 · Cited by 2
Pharmacological interventions for treating dyslipidemia in patients with HIV infection
Martí-Carvajal, A. J., & Cruciani, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008869 · Cited by 2
Retracted
Beneficial Pleiotropic Effects of Statins
Lunder, M., Žiberna, L., Drevenšek, G., & Šabović, M. (2011) · Slovenian Medical Journal · Cited by 2
Pharmacology of statins: A brief overview
Patel, B. (2014) · Nurse Prescribing · doi:10.12968/npre.2014.12.9.451 · Cited by 2
One feature doesn't fit all
Chua, H. E., Bhowmick, S. S., & Tucker‐Kellogg, L. (2014) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2649387.2649424 · Cited by 2
Crude Ethanol Extract of Pithecellobium ellipticum as a Potential Lipid‐Lowering Treatment for Hypercholesterolaemia
Wong, J. P. C., Wijaya, S., Ting, K., Wiart, C., Mustafa, K., Shipton, F. N., & Khoo, T.-J. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/492703 · Cited by 2
A hypothesis about the potential role of statin administration as adjuvant treatment in the management of Merlin-deficient tumors
Brotis, A. G., Tsitsopoulos, P. P., Tsiamalou, P., Τάσιου, Α., Rocco, C. D., & Fountas, K. N. (2014) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2014.02.003 · Cited by 2
Statins and Cancer: A Potential Link?
Thompson, J. S., Sood, A. K., & Arora, R. R. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31819df9cd · Cited by 2
Homozygous Familial Hypercholesterolemia: Case report and Review of Literature
Khurana, V. K. (2014) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20140202.15 · Cited by 2
Lipid management in Type 2 diabetes: the case for combination therapy?
Saely, C. H., Drexel, V., Vonbank, A., & Drexel, H. (2011) · Therapy · doi:10.2217/thy.11.5 · Cited by 2
A Model of Cholesterol Metabolism and Transport
Sy, J. (2008) · Cited by 2
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Madasamy, S., Liu, D., Lundry, J., Alderete, B. E., Kong, R., Robinson, J. P., Wu, A. H. B., & Amento, E. P. (2017) · Journal of Visualized Experiments · doi:10.3791/56596 · Cited by 2
Fats and Oils as Sources of Bioactive Molecules
Kumar, A., Kushwaha, P. P., Varddhan, S., Waseem, M., Husain, H., Singh, A. K., & Kumar, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-42319-3_6 · Cited by 2
Intradiscal Therapeutics for Degenerative Disc Disease
Mowbray, J., Shen, B., & Diwan, A. D. (2021) · Springer eBooks · doi:10.1007/978-3-319-44424-6_92 · Cited by 2
Rapid Regression of Carotid Artery Stenosis Shortly after Intensive Medical Therapy
Park, S. Y., Rhi, S. H., Chung, J. Y., Lee, C.-H., Shin, B., & Kang, H. G. (2022) · Tomography · doi:10.3390/tomography8010044 · Cited by 2
Clinical strategies for reducing cholesterol levels
Lardinois, C. K., & Karr, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00027-4 · Cited by 2
Use of Statins in Dental Implantology and Their Impact on Osseointegration: Animal Studies
Katanec, T., & Gabrić, D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108953 · Cited by 2
Research Progress in the Clinical Treatment of Familial Hypercholesterolemia
Ai, J.-Y., Zhao, P.-C., Zhang, W., & Rao, G.-W. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230202111849 · Cited by 2
Low-dose atorvastatin therapy induced rhabdomyolysis in a liver cirrhosis patient – a case report
Bhattarai, S., Pradhan, S. R., & Bhattarai, S. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001231 · Cited by 2
Navigating the Statin Landscape: A Comprehensive Review of Stroke Prevention Strategies
Deolikar, V., Raut, S. S., Toshniwal, S. S., Kumar, S., & Acharya, S. (2024) · Cureus · doi:10.7759/cureus.53555 · Cited by 2
Gender Differences in Response to Statin Therapy in Ischemic Stroke Patients With SLCO1B1 388A>G Polymorphism: A Clinical Study
Sabokbar, T., Sharifipour, E., Zamanlu, M., Movahhed, T. K., Aghaali, M., Salarvand, M., Javaherian, F., & Hejazi, S. A. (2023) · Biomedical Research Bulletin · doi:10.34172/biomedrb.2023.19 · Cited by 2
Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies
Garabet, R., Herr, S. J., Griffin, N., & Reddy, K. A. (2024) · Rheumatology International · doi:10.1007/s00296-024-05559-8 · Cited by 2
The Association Between Dyslipidemia and Its Treatment with Erectile Dysfunction
Pittaras, A. E., Avranas, K., Imprialos, K. P., Faselis, C. J., & Kokkinos, P. F. (2014) · Springer eBooks · doi:10.1007/978-3-319-08272-1_13 · Cited by 2
Disruption of Fungi Cell Membranes by Polyenes, Azoles, Allylamines, Amino Acids and Peptides
Aderiye, B. I. (2015) · International Scientific Research Journal · doi:10.18483/irjsci.13 · Cited by 2
New Frontier in Lipids: PCSK9 Inhibitors and Implications for the Life Insurance Industry
Tarpley, A. J. (2018) · Journal of Insurance Medicine · doi:10.17849/insm-47-4-1-6.1 · Cited by 2
Primary and Novel Lipid-Lowering Therapies to Reduce Risk in Patients With Peripheral Arterial Disease
Chionchio, A., Galmer, A. M., & Hirsh, B. J. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0791-7 · Cited by 2
A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.
Wang, J., Chi, C., Peter, W. L. S., Carlson, A., Loth, M., Pradhan, P. M., Liang, Y., Chen, W.-Y., Lenskaia, T., Robinson, J. G., et al. (2020) · PubMed Central · Cited by 2
Differences in susceptibility of HT‐29 and A549 cells to statin‐induced toxicity: An investigation using high content screening
Wei, G., Xue, L., Zhu, Y.-D., Qian, X., Zou, L., Jin, Q., Wang, D., & Ge, G. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22699 · Cited by 2
Effect of atorvastatin on testosterone levels
Shawish, M. I., Bagheri, B., Musini, V. M., Adams, S. P., & Wright, J. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013211 · Cited by 3
Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traitsPreprint
So, H., Chau, C. K., & Zhao, K. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170241 · Cited by 2
Utilization Pattern of Statins in an Indian Population.
Raj, N. (2012) · Cited by 2
Cofactors
Haase, I., Fischer, M. J., Bacher, A., Eisenreich, W., & Rohdich, F. (2012) · Wiley eBooks · doi:10.1002/9781118391815.ch10 · Cited by 2
Differentiating erythroblasts adapt to turbulent flow by accelerating maturation and activating cholesterol biosynthesisPreprint
Iacono, G., Abay, A., Gallego‐Murillo, J. S., Aglialoro, F., Yağcı, N., Fu, K., Svendsen, A. F., Lindern, M. V., & van den Akker, E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.08.570773 · Cited by 2
Multifunctionality of statins as antimicrobials
Plotkin, B. J., Borrelli, A., Erbst, M., Zheng, V., Konaklieva, M. I., Schileru, N., & Sigar, I. M. (2022) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2022.11.3.0114 · Cited by 1
Efficacy and Safety of Statins in Ethnic Differences: A Lesson for Application in Indigenous Australian Patient Care
Gebremichael, L. G., Suppiah, V., Wiese, M. D., Mackenzie, L., Phillips, C., Williams, D. B., & Roberts, M. S. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0152 · Cited by 1
Analysis of HMGB-1 level before and after providing atorvastatin standard therapy in coronary artery disease patients with type-2 diabetes mellitus compared to without type-2 diabetes mellitus
Handayani, W., Suharjono, S., & Yogiarto, M. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0442 · Cited by 1
COMBINED EFFECTS OF SIMVASTATIN AND CALCIUM HYDROXIDE VERSUS MINERAL TRIOXIDE AGGREGATE IN DIRECT PULP CAPPING OF RABBIT’S INCISORS (HISTOLOGICAL STUDY)
Elkaramany, S. M., Elnozahy, A. A., El-Hak, A., & Khalil, N. (2023) · Alexandria Dental Journal · doi:10.21608/adjalexu.2022.120126.1254 · Cited by 1
Comparison of atorvastatin and simvastatin modulation on adiponectin and insulin resistance in non-diabetic dyslipidemic patients
Megawaty, M., Muzayyidah, M., Djabir, Y. Y., Mappangara, I., & Palinggi, B. P. (2023) · Eastern Journal Of Medicine · doi:10.5505/ejm.2023.80912 · Cited by 1
Challenges in Conducting Clinical Trials for Preeclampsia
Bank, T. C., Kline, D., & Costantine, M. M. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01276-y · Cited by 1
Association between genetic polymorphisms and other attributing factors with lipid profiles among statin users: a cross-sectional retrospective study
Shamsudin, A. F., Sulong, S., Ahmad, I., & Bakar, N. S. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00523-4 · Cited by 1
Atherosclerosis
Mayer, F., Innerhofer, R., Köller, T., & Binder, C. J. (2024) · Learning materials in biosciences · doi:10.1007/978-3-031-64591-4_10 · Cited by 1
Recurrent Syncope During Migraine Attacks
da Costa, M. D., Vicente, B. N., Sotero, F. D., & Martins, I. P. (2024) · Acta Médica Portuguesa · doi:10.20344/amp.22134 · Cited by 1
Effect of Simvastatin on Irradiated Primary Vestibular Schwannoma Cells
Wiefels, M. D., Bracho, O. R., Marasigan, M., Telischi, F. F., Ivan, M. E., Welford, S. M., Fernández‐Valle, C., & Dinh, C. T. (2025) · Otology & Neurotology · doi:10.1097/mao.0000000000004469 · Cited by 1
Pharmacokinetic comparison between the fixed-dose combination of rosuvastatin/ezetimibe 2.5/10 mg and the co-administration of individual formulations in healthy subjects
Lee, D., Hwang, S., Lee, T., Yu, K., & Lee, S. (2025) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2025.33.e6 · Cited by 1
Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports
Shaleha, R. R., Yuliana, A., Amin, S., Levita, J., & Sumiwi, S. A. (2025) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s542721 · Cited by 1
Criterion-guided polypharmacy side effects prediction with dual-view contrastive learning
Wang, Y., Ma, H., Gao, Z., Li, Z., & Chang, L. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.113814 · Cited by 1
Lipid metabolism disorders in metabolic syndrome
Polyakova, E. A. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6539 · Cited by 2
Effect of Lignin and other Biopolymers on Hyperlipidemia and Gut Microbiota
Abu-Omar, A., Hasan, E., Gil-Chávez, J., Athamneh, T., Abazid, H., Gurikov, P. A., & Al‐Najjar, M. A. A. (2025) · Jordan Journal of Pharmaceutical Sciences · doi:10.35516/jjps.v18i3.2077 · Cited by 1

Authors: Stancu, C., & Sima, A.
Affiliations: Romanian Academy (RO)
Corresponding author: Sima, Anca
ORCID: Stancu, Camelia
Sima, Anca
Venue: Journal of Cellular and Molecular Medicine
Publisher: Wiley
Published: 2001-10
Volume: 5
Issue: 4
Pages: 378-387
ISSN: 1582-1838 (ISSN-L)
1582-4934
DOI: 10.1111/j.1582-4934.2001.tb00172.x
PMC: PMC6740083
OpenAlex: W2006572302
Cited by: 911
References: 42
Citations by year: 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
FWCI: 0.55
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2038 d)
Locations: Journal of Cellular and Molecular Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
MeSH terms: Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins: mechanism of action and effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks